Download PDF
Thorac Cardiovasc Surg 2014; 62(01): 018-025
DOI: 10.1055/s-0033-1360509
Review Article
Georg Thieme Verlag KG Stuttgart · New York

The MitraClip System: A Systematic Review of Indications, Procedural Requirements, and Guidelines

Dorothee HL Bail
1   Competence-Center Quality Assurance, Medical Service of Statutory, Healthcare Insurance, Tuebingen and Stuttgart, Germany
2   Asklepios Stadtklinik Bad Tölz, Bad Tölz, Germany
,
Klaus Doebler
1   Competence-Center Quality Assurance, Medical Service of Statutory, Healthcare Insurance, Tuebingen and Stuttgart, Germany
› Author Affiliations
Further Information

Publication History

03 May 2013

20 September 2013

Publication Date:
02 December 2013 (online)

   Permissions and Reprints All articles of this category

Abstract

Background Transcatheter interventions (TIs) are new treatment options for patients with severe mitral valve regurgitation (MR) who cannot undergo open mitral valve surgery (oMVS). Despite the lack of scientific evidence demonstrating the benefit of these procedures, there has been a steady increase in their use. The aim of this study was to evaluate whether there are any indication criteria, process, and structural requirements, or scientific society and institutional guidelines for the use of the MitraClip System (Abbott Vascular-Structural Heart, Menlo Park, California, United States).

Method A systematic literature search was conducted using the common medical and scientific databases. Of a total of 1,395 publications, 42 publications met the inclusion criteria and were included for the evaluation.

Results Despite a general lack of high-quality evidence and of consensus recommendations from scientific societies or institutions, an assessment of indication criteria and process and structural requirements for the use of the MitraClip System, including noncontrolled studies, was possible. The majority of studies agree that an interdisciplinary heart team including a cardiothoracic surgeon, an interventional cardiologist, and an echocardiographic specialist should actively participate in clinical decision making, and in the procedure itself. Participation in a scientific-based registry is strongly recommended.

Conclusions The MitraClip System is a promising procedure, but evidence-based indication criteria, structural, and process requirements for its use are lacking. Further results from prospective, randomized controlled trials are needed to determine patients, potential adverse events, device durability, and long-term follow-up. MitraClip should be used in only a small number of centers with procedure-specific, high-quality surgical and interventional experience, and training.

Keywords

MitraClip - mitral regurgitation - mitral valve repair - transcatheter interventions
 

  • Reference

  • 1 Enriquez-Sarano M, Schaff HV, Orszulak TA, Tajik AJ, Bailey KR, Frye RL. Valve repair improves the outcome of surgery for mitral regurgitation. A multivariate analysis. Circulation 1995; 91 (4) 1022-1028
    CrossrefPubMedGoogle Scholar
  • 2 Bonow RO, Carabello BA, Kanu C , et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines; Society of Cardiovascular Anesthesiologists; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 2006; 114 (5) e84-e231
    CrossrefPubMedGoogle Scholar
  • 3 Vahanian A, Alfieri O, Andreotti F , et al; ESC Committee for Practice Guidelines (CPG); Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC); European Association for Cardio-Thoracic Surgery (EACTS). Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg 2012; 42 (4) S1-S44
    CrossrefPubMedGoogle Scholar
  • 4 Carabello BA. The current therapy for mitral regurgitation. J Am Coll Cardiol 2008; 52 (5) 319-326
    CrossrefPubMedGoogle Scholar
  • 5 Vassileva CM, Boley T, Markwell S, Hazelrigg S. Meta-analysis of short-term and long-term survival following repair versus replacement for ischemic mitral regurgitation. Eur J Cardiothorac Surg 2011; 39 (3) 295-303
    CrossrefPubMedGoogle Scholar
  • 6 ACCESS. ACCESS-Europe A Two-Phase Observational Study of the MitraClip® System in Europe. Available at: http://clinicaltrialfeedsorg/clinical-trials/show/NCT01288976 . Accessed on June 19th, 2012.
    PubMedGoogle Scholar
  • 7 Mirabel M, Iung B, Baron G , et al. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery?. Eur Heart J 2007; 28 (11) 1358-1365
    CrossrefPubMedGoogle Scholar
  • 8 Boekstegers P, Hausleiter J, Baldus S , et al. Interventionelle Behandlung der Mitralklappeninsuffizienz mit dem MitraClip-Verfahren. Kardiologe 2013; 7: 91-104
    CrossrefPubMedGoogle Scholar
  • 9 Nickenig G, Mohr FW, Kelm M , et al. Konsensus der Deutschen Gesellschaft für Kardiologie - Herz-und Kreislaufforschung und der Deutschen Gesellschaft für Thorax-, Herz- und Gefäßchirurgie zur Behandlung der Mitralinsuffizienz. Kardiologe 2013; 7: 76-90
    CrossrefPubMedGoogle Scholar
  • 10 Feldman T, Foster E, Glower DD , et al; EVEREST II Investigators. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med 2011; 364 (15) 1395-1406
    CrossrefPubMedGoogle Scholar
  • 11 NHC. Transcatheter mitral valve repair for severe mitral valve regurgitation. New Zealand: National Health Commitee; 2011: 1-8
    Google Scholar
  • 12 Maisano F, Godino C, Giacomini A , et al. Patient selection for MitraClip therapy impaired left ventricular systolic function. Minerva Cardioangiol 2011; 59 (5) 455-471
    PubMedGoogle Scholar
  • 13 Auricchio A, Schillinger W, Meyer S , et al; PERMIT-CARE Investigators. Correction of mitral regurgitation in nonresponders to cardiac resynchronization therapy by MitraClip improves symptoms and promotes reverse remodeling. J Am Coll Cardiol 2011; 58 (21) 2183-2189
    CrossrefPubMedGoogle Scholar
  • 14 Baldus S, Schillinger W, Franzen O , et al; German Transcatheter Mitral Valve Interventions (TRAMI) investigators. MitraClip therapy in daily clinical practice: initial results from the German transcatheter mitral valve interventions (TRAMI) registry. Eur J Heart Fail 2012; 14 (9) 1050-1055
    CrossrefPubMedGoogle Scholar
  • 15 Bohnenblust H, Hitz P, Stettbacher D , et al. Perkutane, Katheter-basierte Behandlung der schweren Mitralklappeninsuffizienz (Percutaneous Mitral Valve Repair). Medical Board; 2010
    Google Scholar
  • 16 Doebler K, Boukamp K, Mayer ED. Indication and structures and management of transcatheter aortic valve implantation: a review of the literature. Thorac Cardiovasc Surg 2012; 60 (5) 309-318
    Article in Thieme ConnectPubMedGoogle Scholar
  • 17 Rosenhek R, Iung B, Tornos P , et al. ESC Working Group on Valvular Heart Disease Position Paper: assessing the risk of interventions in patients with valvular heart disease. Eur Heart J 2012; 33 (7) 822-828 , 828a, 828b
    CrossrefPubMedGoogle Scholar
  • 18 Alegria-Barrero E, Chan PH, Paulo M , et al. Edge-to-edge percutaneous repair of severe mitral regurgitation—state-of-the-art for Mitraclip® implantation. Circ J 2012; 76 (4) 801-808
    CrossrefPubMedGoogle Scholar
  • 19 Medical Service Advisory Committee. Final Decision Analytic Protocol (DAP) to guide the assessment of reduction of mitral regurgitation through tissue approximation using transvenous/transseptal techniques; Australian Goverment - Departement of Health and Ageing. Available at: http://www msac gov au/internet/msac/publishing nsf/Content/1192 . Accessed May 2012
    PubMedGoogle Scholar
  • 20 Conradi L, Treede H, Franzen O , et al. Impact of MitraClip™ therapy on secondary mitral valve surgery in patients at high surgical risk. Eur J Cardiothorac Surg 2011; 40 (6) 1521-1526
    PubMedGoogle Scholar
  • 21 Divchev D, Kische S, Paranskaya L , et al. In-hospital outcome of patients with severe mitral valve regurgitation classified as inoperable and treated with the MitraClip® device. J Interv Cardiol 2012; 25 (2) 180-189
    CrossrefPubMedGoogle Scholar
  • 22 Feldman T, Cilingiroglu M. Percutaneous leaflet repair and annuloplasty for mitral regurgitation. J Am Coll Cardiol 2011; 57 (5) 529-537
    CrossrefPubMedGoogle Scholar
  • 23 Franzen O, Seiffert M, Baldus S , et al. Percutaneous mitral valve repair as a bail-out strategy for patients with severe mitral regurgitation after cardiac surgery. J Thorac Cardiovasc Surg 2011; 142 (1) 227-230
    CrossrefPubMedGoogle Scholar
  • 24 Franzen O, van der Heyden J, Baldus S , et al. MitraClip® therapy in patients with end-stage systolic heart failure. Eur J Heart Fail 2011; 13 (5) 569-576
    CrossrefPubMedGoogle Scholar
  • 25 Glower D, Ailawadi G, Argenziano M , et al; EVEREST II Investigators. EVEREST II randomized clinical trial: predictors of mitral valve replacement in de novo surgery or after the MitraClip procedure. J Thorac Cardiovasc Surg 2012; 143 (4, Suppl): S60-S63
    CrossrefPubMedGoogle Scholar
  • 26 Holmes Jr DR, Mack MJ, Kaul S , et al; American Heart Association; American Society of Echocardiography; European Association for Cardio-Thoracic Surgery; Heart Failure Society of America; Mended Hearts; Society of Cardiovascular Anesthesiologists; Society of Cardiovascular Computed Tomography; Society for Cardiovascular Magnetic Resonance. 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement: developed in collaboration with the American Heart Association, American Society of Echocardiography, European Association for Cardio-Thoracic Surgery, Heart Failure Society of America, Mended Hearts, Society of Cardiovascular Anesthesiologists, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. Catheter Cardiovasc Interv 2012; 79 (7) 1023-1082
    CrossrefPubMedGoogle Scholar
  • 27 Jilaihawi H, Hussaini A, Kar S. MitraClip: a novel percutaneous approach to mitral valve repair. J Zhejiang Univ Sci B 2011; 12 (8) 633-637
    CrossrefPubMedGoogle Scholar
  • 28 Maisano F, Franzen O, Baldus S , et al. Percutaneous Mitral Valve Interventions in the Real World: Early and 1-Year Results From the ACCESS-EU, A Prospective, Multicenter, Nonrandomized Post-Approval Study of the MitraClip Therapy in Europe. J Am Coll Cardiol 2013; 62 (12) 1052-1061
    CrossrefPubMedGoogle Scholar
  • 29 Neuss M, Schau T, Schoepp M , et al. Patient selection criteria and midterm clinical outcome for MitraClip therapy in patients with severe mitral regurgitation and severe congestive heart failure. Eur J Heart Fail 2013; 15 (7) 786-795
    CrossrefPubMedGoogle Scholar
  • 30 NICE Percutaneous mitral valve annuloplasty. Available at: http://www.nice.org.uk/nicemedia/live/12351/49902/49902.pdf . Accessed: July 2010
    PubMed
  • 31 Obadia JF. MitraClip: Actual data and perspectives. Congrès EBR 2012, Marseille, France, May 3–4 2012
    PubMedGoogle Scholar
  • 32 Siegel RJ, Luo H, Biner S. Transcatheter valve repair/implantation. Int J Cardiovasc Imaging 2011; 27 (8) 1165-1177
    CrossrefPubMedGoogle Scholar
  • 33 Siegel RJ, Luo H. Echocardiography in transcatheter aortic valve implantation and mitral valve clip. Korean J Intern Med 2012; 27 (3) 245-261
    CrossrefPubMedGoogle Scholar
  • 34 Smith T, McGinty P, Bommer W , et al. Prevalence and echocardiographic features of iatrogenic atrial septal defect after catheter-based mitral valve repair with the MitraClip system. Catheter Cardiovasc Interv 2012; 80 (4) 678-685
    CrossrefPubMedGoogle Scholar
  • 35 Sürder D, Pedrazzini G, Gaemperli O , et al. Predictors for efficacy of percutaneous mitral valve repair using the MitraClip system: the results of the MitraSwiss registry. Heart 2013; 99 (14) 1034-1040
    CrossrefPubMedGoogle Scholar
  • 36 Krumsdorf U, Chorianopoulos E, Rottbauer W, Katus H, Bekeredjian R. Percutaneous aortic valve implantation improves quality of life in a geriatric patient population. EuroIntervention 2011; 7 (May Suppl). http://www.pcronline.com/eurointervention/search/?keyword_string=krumsdorf
    PubMedGoogle Scholar
  • 37 Swaans MJ, Van den Branden BJ, Van der Heyden JA , et al. Three-dimensional transoesophageal echocardiography in a patient undergoing percutaneous mitral valve repair using the edge-to-edge clip technique. Eur J Echocardiogr 2009; 10 (8) 982-983
    CrossrefPubMedGoogle Scholar
  • 38 Tamburino C, Immè S, Barbanti M , et al. Reduction of mitral valve regurgitation with Mitraclip® percutaneous system. Minerva Cardioangiol 2010; 58 (5) 589-598
    PubMedGoogle Scholar
  • 39 Taramasso M, Denti P, Buzzatti N , et al. Mitraclip therapy and surgical mitral repair in patients with moderate to severe left ventricular failure causing functional mitral regurgitation: a single-centre experience. Eur J Cardiothorac Surg 2012; 42 (6) 920-926
    CrossrefPubMedGoogle Scholar
  • 40 Treede H, Schirmer J, Rudolph V , et al. A heart team's perspective on interventional mitral valve repair: percutaneous clip implantation as an important adjunct to a surgical mitral valve program for treatment of high-risk patients. J Thorac Cardiovasc Surg 2012; 143 (1) 78-84
    CrossrefPubMedGoogle Scholar
  • 41 Turi ZG, Rosenbloom M. An option for the high-comorbidity patient with mitral regurgitation. J Am Coll Cardiol 2012; 59 (2) 140-142
    CrossrefPubMedGoogle Scholar
  • 42 Van den Branden BJ, Swaans MJ, Post MC , et al. Percutaneous edge-to-edge mitral valve repair in high-surgical-risk patients: do we hit the target?. JACC Cardiovasc Interv 2012; 5 (1) 105-111
    CrossrefPubMedGoogle Scholar
  • 43 Whitlow PL, Feldman T, Pedersen WR , et al; EVEREST II Investigators. Acute and 12-month results with catheter-based mitral valve leaflet repair: the EVEREST II (Endovascular Valve Edge-to-Edge Repair) High Risk Study. J Am Coll Cardiol 2012; 59 (2) 130-139
    CrossrefPubMedGoogle Scholar
  • 44 Yuksel UC, Kapadia SR, Tuzcu EM. Percutaneous mitral repair: patient selection, results, and future directions. Curr Cardiol Rep 2011; 13 (2) 100-106
    CrossrefPubMedGoogle Scholar
  • 45 Zamorano JL, Badano LP, Bruce C , et al. EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease. J Am Soc Echocardiogr 2011; 24 (9) 937-965
    PubMedGoogle Scholar
  • 46 Vahanian A, Iung B. 'Edge to edge' percutaneous mitral valve repair in mitral regurgitation: it can be done but should it be done?. Eur Heart J 2010; 31 (11) 1301-1304
    CrossrefPubMedGoogle Scholar
  • 47 Maisano F, Alfieri O, La Canna G. Percutaneous mitral repair with the MitraClip. Ann Fr Anesth Reanim 2011; 30 (Suppl. 01) S33-S37
    PubMedGoogle Scholar
  • 48 Tamburino C, Ussia GP, Maisano F , et al. Percutaneous mitral valve repair with the MitraClip system: acute results from a real world setting. Eur Heart J 2010; 31 (11) 1382-1389
    CrossrefPubMedGoogle Scholar
  • 49 NICE. National Institute for Health and Clinical Excellence: Percutaneous mitral valve leaflet repair for mitral regurgitation. Available at: http://guidance.nice.org.uk/ipg309 . Accessed on June 19, 2012
    PubMedGoogle Scholar
  • 50 Feldman T, Glower D. Patient selection for percutaneous mitral valve repair: insight from early clinical trial applications. Nat Clin Pract Cardiovasc Med 2008; 5 (2) 84-90
    CrossrefPubMedGoogle Scholar
  • 51 Kappetein AP, Head SJ, Généreux P , et al; Valve Academic Research Consortium-2. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Thorac Cardiovasc Surg 2013; 145 (1) 6-23
    CrossrefPubMedGoogle Scholar
  • 52 AHRQ-ECRI Institute. AHRQ Healthcare Horizon Scanning System Potential High Impact Interventions: Priority Area 03: Cardiovascular Disease. (Prepared by ECRI Institute under Contract No. HHSA290201000006C.) Rockville, MD: Agency for Healthcare Research and Quality. Available at: http://www.effectivehealthcare.ahrq.gov/index.cfm . Accessed July 24, 2012
    PubMedGoogle Scholar
  • 53 Conradi L, Treede H, Baldus S, Seiffert M, Blankenberg S, Reichenspurner H. Treating mitral regurgitation: a surgical and interventional update. Herz 2011; 36 (8) 677-685
    CrossrefPubMedGoogle Scholar